 | Up a level |
Fontanellaz, M.; Christe, A.; Christodoulidis, S.; Dack, E.; Roos, J.; Drakopoulos, D.; Sieron, D.; Peters, A.; Geiser, T.; Funke-Chambour, M.; Heverhagen, J.; Hoppe, H.; Exadaktylos, A. K.; Ebner, L.; Mougiakakou, S. (2024). Computer-Aided Diagnosis System for Lung Fibrosis: From the Effect of Radiomic Features and Multi-Layer-Perceptron Mixers to Pre-Clinical Evaluation. IEEE access, 12, pp. 25642-25656. IEEE 10.1109/ACCESS.2024.3350430
Funke-Chambour, M.; Bridevaux, P.-O.; Clarenbach, C. F.; Soccal, P. M.; Nicod, L. P.; von Garnier, C. (2021). Swiss Recommendations for the Follow-Up and Treatment of Pulmonary Long COVID. Respiration, 100(8), pp. 826-841. Karger 10.1159/000517255
Guler, S.A.; Funke-Chambour, M. (2019). Antifibrotics: Shrinking the Box of Therapeutic Uncertainty. Respiration, 97(3), pp. 202-204. Karger 10.1159/000494275
Funke-Chambour, M.; Ott, S. R. (2013). Rare pathogens causing pneumonia. Deutsche medizinische Wochenschrift, 138(40), pp. 2019-2022. Thieme 10.1055/s-0033-1349509
